These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4853242)

  • 1. Modifications of the in vitro metabolism of the hepatotoxic pyrrolizidine alkaloid, monocrotaline.
    Chesney CF; Hsu IC; Allen JR
    Res Commun Chem Pathol Pharmacol; 1974 Jul; 8(3):567-70. PubMed ID: 4853242
    [No Abstract]   [Full Text] [Related]  

  • 2. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some factors affecting the conversion of pyrrolizidine alkaloids to N-oxides and to pyrrolic derivatives in vitro.
    White IN; Mattocks AR
    Xenobiotica; 1971; 1(4):503-5. PubMed ID: 4277657
    [No Abstract]   [Full Text] [Related]  

  • 4. Dietary selenium status and pyrrolizidine alkaloid metabolism in vitro by rat liver microsomes.
    Shull LR; Buckmaster GW; Cheeke PR
    Res Commun Chem Pathol Pharmacol; 1977 Jun; 17(2):337-40. PubMed ID: 877417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsomal metabolism of pyrrolizidine alkaloids from Senecio jacobaea. Isolation and quantification of 6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine and N-oxides by high performance liquid chromatography.
    Ramsdell HS; Kedzierski B; Buhler DR
    Drug Metab Dispos; 1987; 15(1):32-6. PubMed ID: 2881756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro metabolism of isoline, a pyrrolizidine alkaloid from Ligularia duciformis, by rodent liver microsomal esterase and enhanced hepatotoxicity by esterase inhibitors.
    Tang J; Akao T; Nakamura N; Wang ZT; Takagawa K; Sasahara M; Hattori M
    Drug Metab Dispos; 2007 Oct; 35(10):1832-9. PubMed ID: 17639025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine.
    Xia Q; Yan J; Chou MW; Fu PP
    Toxicol Lett; 2008 May; 178(2):77-82. PubMed ID: 18395999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts.
    Yan J; Xia Q; Chou MW; Fu PP
    Toxicol Ind Health; 2008 Apr; 24(3):181-8. PubMed ID: 18842697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The conversion of pyrrolizidine alkaloids to N-oxides and to dihydropyrrolizine derivatives by rat-liver microsomes in vitro.
    Mattocks AR; White IN
    Chem Biol Interact; 1971 Oct; 3(5):383-96. PubMed ID: 4400405
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between in vitro metabolism of pyrrolizidine alkaloids and extrahepatic toxicity in vivo.
    Huxtable RJ; Wild SL
    Proc West Pharmacol Soc; 1994; 37():109-11. PubMed ID: 7984636
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of spironolactone treatment on the cytochrome P450-mediated metabolism of the pyrrolizidine alkaloid senecionine by hepatic microsomes from rats and guinea pigs.
    Chung WG; Buhler DR
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):314-9. PubMed ID: 8048076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activation of pyrrolizidine alkaloids by human, rat and avocado microsomes.
    Couet CE; Hopley J; Hanley AB
    Toxicon; 1996 Sep; 34(9):1058-61. PubMed ID: 8896199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms for pyrrolizidine alkaloid activation and detoxification.
    Buhler DR; Miranda CL; Kedzierski B; Reed RL
    Adv Exp Med Biol; 1991; 283():597-603. PubMed ID: 2069028
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatotoxic effects due to pyrrolizidine alkaloid N-oxides.
    Mattocks AR
    Xenobiotica; 1971; 1(4):563-5. PubMed ID: 4950811
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors affecting the chronic hepatotoxicity of pyrrolizidine alkaloids.
    Jago MV
    J Pathol; 1971 Sep; 105(1):1-11. PubMed ID: 5129752
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of monocrotaline-induced hepatic genotoxicity in rats.
    Petry TW; Sipes IG
    Carcinogenesis; 1987 Mar; 8(3):415-9. PubMed ID: 3102099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further evidence on the intramolecular lactonization in rat liver microsomal metabolism of 12-O-acetylated retronecine-type pyrrolizidine alkaloids.
    Tang J; Wang Z; Akao T; Hattori M
    Nat Prod Commun; 2013 Nov; 8(11):1545-6. PubMed ID: 24427937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological reactive intermediates of pyrrolizidine alkaloids.
    Buhler DR; Kedzierski B
    Adv Exp Med Biol; 1986; 197():611-20. PubMed ID: 3766284
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative effects of the pyrrolizidine alkaloids jacobine and monocrotaline on hepatic drug metabolising enzymes in the rat.
    Miranda CL; Cheeke PR; Buhler DR
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):573-87. PubMed ID: 6775360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new pyrrolizidine alkaloid metabolite, 19-hydroxysenecionine isolated from mouse hepatic microsomes in vitro.
    Eastman DF; Segall HJ
    Drug Metab Dispos; 1982; 10(6):696-9. PubMed ID: 6130926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.